DUBLIN, Ireland - Trinity Biotech plc (NASDAQ:TRIB), a leading provider of diagnostic solutions for the healthcare industry, ...

Trinity Biotech ( ($TRIB) ) has issued an announcement. Trinity Biotech announced a positive update regarding the U.S. government’s funding for ...

Although a temporary waiver for essential services was introduced on January 28, 2025, the impact on HIV testing programs using Trinity Biotech's products is uncertain. This pause may affect the ...

Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based diagnostic company with a market capitalization of $23.7 million and current trading price of $1.32, is evaluating the potential effects of a recent ...

Trinity Biotech is also transferring its HIV test production to an offshore manufacturing partner, a move approved by the World Health Organization. The company expects its preeclampsia and ...

Trinity Biotech is also transferring its HIV test production to an offshore manufacturing partner, a move approved by the World Health Organization. The company expects its preeclampsia and prostate ...

Trinity Biotech has acquired Metabolomics Diagnostics, an Irish deep-tech company known for its preeclampsia risk prediction test, PrePsia, which is expected to launch in the U.S. in 2025 through ...

Trinity Biotech has received earlier than expected approval from t Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of ...